Results 171 to 179 of about 13,875 (179)

Covalent fragment-based drug discovery as a strategy to combat leishmaniasis

Acta Crystallographica Section A Foundations and Advances
openaire   +1 more source

Multiparameter Kinetic Analysis for Covalent Fragment Optimization by Using Quantitative Irreversible Tethering (qIT)

ChemBioChem, 2020
Alan Armstrong, Rhodri Morgan, Tsz Lam Matthew Wong   +2 more
exaly  

Tethering: Fragment-Based Drug Discovery

Annual Review of Biophysics and Biomolecular Structure, 2004
James Wells
exaly  

AutoDrug: fully automated macromolecular crystallography workflows for fragment-based drug discovery

Acta Crystallographica Section D: Biological Crystallography, 2013
Aina Cohen, Scott E Mcphillips, Timothy M Mcphillips   +2 more
exaly  

Counting on Fragment Based Drug Design Approach for Drug Discovery

Current Topics in Medicinal Chemistry, 2019
Om Silakari, Pankaj Kumar Singh, Aanchal Kashyap   +2 more
exaly  

Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery

Bioorganic and Medicinal Chemistry Letters, 2011
Laura Silvian, Kieu Duyen Nguyen, Michael J Romanowski   +2 more
exaly  

Covalent Inhibition in Drug Discovery: Filling the Void in Literature

Current Topics in Medicinal Chemistry, 2018
Clement Agoni, Geraldene Munsamy, Imane Bjij   +2 more
exaly  

Structure‐Based and Fragment‐Based GPCR Drug Discovery

ChemMedChem, 2014
John Christopher
exaly  

Leveraging the Fragment Molecular Orbital and MM-GBSA Methods in Virtual Screening for the Discovery of Novel Non-Covalent Inhibitors Targeting the TEAD Lipid Binding Pocket

International Journal of Molecular Sciences
Jianmin Wang, Sungho Moon, Kyoung Tai No   +2 more
exaly